AAV9-GFP-CIP via ICV injection expressed CIP widely in the brain of mice including midbrain, inhibited hyperphosphorylation of substrate of Cdk5/p25, alleviated the pathologic changes, and improved motor and non-motor symptoms in MPTP/p induced PD mouse model. Here, CDK5 is linked to Parkinson disease.